SEC Form 4/A · accession 0001179110-17-015779
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Craig Barrows
Officer — Executive VP, General Counsel
Period of report
Sep 13, 2017
Accepted (ET)
Dec 21, 2017 · 3:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | Sep 13, 2017 | M | 20,000 | $4.50 | A | 191,500 | D | |
| Common StockF2,F3 | Sep 13, 2017 | S | 14,600 | $6.9455 | D | 176,900 | D | |
| Common StockF3 | Sep 15, 2017 | M | 30,000 | $4.50 | A | 206,900 | D | |
| Common StockF2,F3 | Sep 15, 2017 | S | 22,450 | $6.7284 | D | 184,450 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.50 | Sep 13, 2017 | M | 20,000 | D | Oct 3, 2008 | Oct 3, 2017 | Common Stock | 20,000 | 30,000 | D |
| Stock Option (right to buy)F1 | $4.50 | Sep 15, 2017 | M | 30,000 | D | Oct 3, 2008 | Oct 3, 2017 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1Exercisable as to 12,500 shares commencing on October 3, 2008, 12,500 shares commencing on October 3, 2009, 12,500 shares commencing on October 3, 2010 and 12,500 shares commencing on October 3, 2011.
- F2Weighted average price of shares sold.
- F3This amendment to Form 4 is being filed to correct the total shares held to include restricted shares which were inadvertently excluded from the totals in the original Form 4 filed on September 15, 2017.